Key Market Indicators
New Zealander sales of antidepressants are set to decrease by 17.9% over the next five years. Last year, the country was ranked 23rd in the world, with sales of $5.61 million. Iceland overtook New Zealand in this ranking. Germany, Spain and Italy were the second, third and fourth biggest markets respectively. Since 1998, New Zealand's antidepressants market has declined by an average of 10% each year. In 2026, sales are projected to reach $1.75 million.
